- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 116,290 | 23.08.24 20:43:56 | -0,260 | -0,22% | 116,270 | 116,300 | 116,800 | 116,550 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 103,920 | 23.08.24 20:29:50 | +0,300 | +0,29% | 103,260 | 104,000 | 106,250 | 103,620 |
